- Home
- ALLR vs FCUV Comparison
ALLR vs FCUV Comparison
Compare ALLR & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- FCUV
- Stock Information
- Founded
- ALLR 2004
- FCUV 2012
- Country
- ALLR United States
- FCUV United States
- Employees
- ALLR N/A
- FCUV N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- ALLR Health Care
- FCUV Industrials
- Exchange
- ALLR Nasdaq
- FCUV Nasdaq
- Market Cap
- ALLR 15.8M
- FCUV 15.9M
- IPO Year
- ALLR N/A
- FCUV N/A
- Fundamental
- Price
- ALLR $1.52
- FCUV $2.76
- Analyst Decision
- ALLR Strong Buy
- FCUV
- Analyst Count
- ALLR 1
- FCUV 0
- Target Price
- ALLR $9.00
- FCUV N/A
- AVG Volume (30 Days)
- ALLR 21.5M
- FCUV 63.3K
- Earning Date
- ALLR 11-13-2025
- FCUV 11-06-2025
- Dividend Yield
- ALLR N/A
- FCUV N/A
- EPS Growth
- ALLR N/A
- FCUV N/A
- EPS
- ALLR N/A
- FCUV N/A
- Revenue
- ALLR N/A
- FCUV $432,983.00
- Revenue This Year
- ALLR N/A
- FCUV N/A
- Revenue Next Year
- ALLR N/A
- FCUV N/A
- P/E Ratio
- ALLR N/A
- FCUV N/A
- Revenue Growth
- ALLR N/A
- FCUV 140.82
- 52 Week Low
- ALLR $0.61
- FCUV $1.80
- 52 Week High
- ALLR $3.71
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- ALLR 52.13
- FCUV 62.72
- Support Level
- ALLR N/A
- FCUV $2.51
- Resistance Level
- ALLR $1.92
- FCUV $3.18
- Average True Range (ATR)
- ALLR 0.19
- FCUV 0.24
- MACD
- ALLR -0.08
- FCUV 0.12
- Stochastic Oscillator
- ALLR 73.79
- FCUV 69.37
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.